Leaders at Cencora continue to monitor the international response and reaction to Russia’s invasion of Ukraine. 

We are pleased to announce that we have resumed domestic and international services in Ukraine. The situation in Ukraine is being closely monitored, and requests will be assessed on a one to one basis and accepted based on feasibility. Cencora will cease new business initiatives in Russia and Belarus while completing support of existing clinical trials and continuing distribution of oncology therapies and other pharmaceutical products for current customers that Cencora is supporting at this time to serve those markets. 

We are experiencing a disruption to international shipments across the surrounding countries due to a reduction of flights and transport routes.

We will continue to share more information as soon as it is available. Please keep checking this page for further updates. If you have any additional questions, please reach out to your local World Courier representative.

For more information about Cencora’s current operations in Eastern Europe, please read this statement from Robert Mauch, Executive Vice President and Chief Operating Officer of Cencora.